Australia’s 2025 flu season lasted weeks longer than it normally does. Hong Kong’s hit so early that the rollout of seasonal ...

The flu rates for the 2025/2026 cold and flu season are at a 25 year high, leaving some to wonder if the flu vaccine is ...

RSV vaccines showed 80% effectiveness against hospitalizations and 81% against critical illness in non-immunocompromised individuals aged 60 and older. Immunocompromised individuals experienced 73% ...

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...

The flu vaccine is recommended annually for all Americans 6 months and older, per the Centers for Disease Control and Prevention — but a new study from Cleveland Clinic suggests that it might not have ...

H3N2 subclade K strain — is responsible for 90% of influenza A cases across the U.S., which has led to double the cases in New Jersey.

Please provide your email address to receive an email when new articles are posted on . RSVpreF had a vaccine effectiveness of 92% for patients aged 60 years or older. Effectiveness remained at 90% or ...

One dose of a bivalent or nonavalent HPV vaccine was noninferior to two doses, the randomized ESCUDDO trial found. Vaccine effectiveness was at least 97% against HPV16 or 18 infection no matter ...

The recombinant zoster vaccine (RZV) Shingrix demonstrated effectiveness in preventing herpes zoster (HZ) and postherpetic neuralgia among adults aged 50 years or older with rheumatoid arthritis (RA).